Kallio, J <br/><br/>
Antenatal dexamethasone treatment decreases plasma catecholamine levels in preterm infants.  [electronic resource] 

 -  Pediatric research  Jun 1998 
 - 801-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0031-3998 
<br/><br/><label>Standard No.: </label>10.1203/00006450-199806000-00014  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antihypertensive Agents--therapeutic use<br/>Birth Weight<br/>Cyclic AMP--blood<br/>Delivery, Obstetric<br/>Dexamethasone--administration & dosage<br/>Epinephrine--blood<br/>Female<br/>Gestational Age<br/>Humans<br/>Hypertension--drug therapy<br/>Infant, Newborn<br/>Infant, Premature--blood<br/>Male<br/>Methoxyhydroxyphenylglycol--analogs & derivatives<br/>Norepinephrine--blood<br/>Pregnancy<br/>Pregnancy Complications, Cardiovascular--drug therapy<br/>Prenatal Care<br/>Regression Analysis<br/>Respiratory Distress Syndrome, Newborn--prevention & control<br/>Tocolytic Agents--therapeutic use